Maharashtra, India

Chirag Anilkumar Shah

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Chirag Anilkumar Shah

Introduction

Chirag Anilkumar Shah is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, holding two patents that showcase his innovative approach to drug formulation and synthesis.

Latest Patents

His latest patents include a pharmaceutical composition of donepezil that exhibits a specific in vitro dissolution profile. This timed release pharmaceutical composition is designed to release less than about 20% w/w of donepezil in 3 to 6 hours, while more than 90% w/w is released after 12 hours when tested in a Paddle dissolution apparatus. Additionally, he has developed an improved process for the preparation of clobazam and its intermediate, which involves the transformation of key compounds into Clobazam through a series of chemical reactions.

Career Highlights

Chirag has worked with prominent companies in the pharmaceutical industry, including Piramal Enterprises Limited and Lupin, Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

He has collaborated with notable coworkers such as Ashutosh Jagtap and Milind Moreshwar Gharpure, further enhancing his innovative capabilities through teamwork and shared expertise.

Conclusion

Chirag Anilkumar Shah's contributions to pharmaceutical innovations reflect his dedication to improving drug formulations and processes. His patents and career achievements highlight his role as a significant inventor in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…